Hollis RL, Miller A, Lankes HA, Wong KK, et al. Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancer. Clin Cancer Res 2025 Dec 11. doi: 10.1158/1078-0432.CCR-25-3042.
PMID: 41378992